Melissa et al. showed that antemortem 1H MRS metabolites (e.g., NAA/Cr and NAA/mIns) were linked to postmortem AD neuropathology, including the amyloid burden, synaptic integrity, and tau pathology [29]. Here, MAPT is linked to Alzheimer disease.